Document Preview Unavailable
Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers
Yap, Desmond Y H; Hai, Jojo; Lee, Paul C H; Zhou, Xueying; Lee, Michael; et al. Clinical and Translational Science Vol. 14, Iss. 5, (Sep 2021): 1769-1779.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library